2008•Zhongguo xin yao zazhiRequires access

Pharmacokinetic properties of huperzine A sustained release tablets in dogs

Zhimin Wu

Open publisher page 0 citations

Abstract

Objective:To study the pharmaeokinetic properties of huperzine A sustained release tablets (test tablets)in dogs with immediate release tablets as the reference.Methods:The test(2 tablets)and reference tablets(4 tablets)of huperzine A(200μg)were administered to six dogs by a two-period cross design method. The HPLC method was applied to determine plasma huperzine A.Non-compartment model method was used to cal- culate the pharmacokinetic parameters.Results:T_(max)of huperzine A for the test and reference tablets was(9.33±1.63)and(3.00±0.92)h,respectively;t_(1/2)was(11.01±2.66)and(4.71±1.00)h;C_(max)was(1.95±0.29)and(6.23±0.91)ng·mL~(-1);AUC_(0~t)was(28.29±2.03)and(27.45±1.83)ng·h·mL~(-1).The relative bioavailability of huperzine A sustained release tablets was(103.06±3.72)%.Conclusion:Huperzine A sus- tained release tablets shows characteristics of slow release,and the two preparations were bioequivalent according to statistical analysis.

About this research paper

What this paper is about

Objective:To study the pharmaeokinetic properties of huperzine A sustained release tablets (test tablets)in dogs with immediate release tablets as the reference.Methods:The test(2 tablets)and reference tablets(4 tablets)of huperzine A(200μg)were administered to six dogs by a two-period cross design method. The HPLC method was applied to determine plasma huperzine A.Non-compartment model method was used to cal- culate the pharmacokinetic parameters.Results:T_(max)of huperzine A for the test and reference tablets was(9.33±1.63)and(3.00±0.92)h,respectively;t_(1/2)was(11.01±2.66)and(4.71±1.00)h;C_(max)was(1.95±0.29)and(6.23±0.91)ng·mL~(-1);AUC_(0~t)was(28.29±2.03)and(27.45±1.83)ng·h·mL~(-1).The relative bioavailability of huperzine A sustained release tablets was(103.06±3.72)%.Conclusion:Huperzine A sus- tained release tablets shows characteristics of slow release,and the two preparations were bioequivalent according to statistical analysis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the pharmaeokinetic properties of huperzine A sustained release tablets (test tablets)in dogs with immediate release tablets as the reference.Methods:The test(2 tablets)and reference tablets(4 tablets)of huperzine A(200μg)were administered to six dogs by a two-period cross design method. The HPLC method was applied to determine plasma huperzine A.Non-compartment model method was used to cal- culate the pharmacokinetic parameters.Results:T_(max)of huperzine A for the test and reference tablets was(9.33±1.63)and(3.00±0.92)h,respectively;t_(1/2)was(11.01±2.66)and(4.71±1.00)h;C_(max)was(1.95±0.29)and(6.23±0.91)ng·mL~(-1);AUC_(0~t)was(28.29±2.03)and(27.45±1.83)ng·h·mL~(-1).The relative bioavailability of huperzine A sustained release tablets was(103.06±3.72)%.Conclusion:Huperzine A sus- tained release tablets shows characteristics of slow release,and the two preparations were bioequivalent according to statistical analysis.

Key concepts: Huperzine A, Bioequivalence, Bioavailability, Immediate release, Pharmacokinetics, Chemistry, Chromatography, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetic properties of huperzine A sustained release tablets in dogs — Research Paper | ScholarLens